Stock CUE CUE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cue Biopharma, Inc.

Equities

CUE

US22978P1066

Real-time Estimate Cboe BZX
Other stock markets
 03:07:52 2024-04-30 pm EDT 		5-day change 1st Jan Change
1.69 USD +19.01% Intraday chart for Cue Biopharma, Inc. +10.00% -37.50%
Apr. 08 Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024
Apr. 08 North American Morning Briefing : Inflation Data, -2- DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jefferies Starts Cue Biopharma With Buy Rating
MT
Piper Sandler Adjusts Price Target on Cue Biopharma to $8 From $7, Maintains Overweight Rating
MT
Cue Biopharma Says Phase 1b Trial of CUE-101 With Pembrolizumab Shows 40% Overall Response Rate
MT
Stifel Adjusts Cue Biopharma's Price Target to $8 From $9, Keeps Buy Rating
MT
Piper Sandler Starts Cue Biopharma at Overweight With $7 Price Target
MT
Oppenheimer Adjusts Cue Biopharma's Price Target to $10 From $26, Maintains Outperform Rating
MT
JMP Securities Adjusts Cue Biopharma's Price Target to $15 From $30, Maintains Market Outperform Rating
MT
Oppenheimer Adjusts Cue Biopharma's Price Target to $26 From $32, Maintains Outperform Rating
MT
Craig-Hallum Adjusts Cue Biopharma's Price Target to $26 From $28, Keeps Buy Rating
MT
HC Wainwright Starts Cue Biopharma at Buy with $20 Price Target
MT
Craig-Hallum Starts Cue Biopharma at Buy with $28 Price Target
MT
CUE BIOPHARMA : Berenberg Starts Cue Biopharma at Buy With $30 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CUE Stock
  4. News Cue Biopharma, Inc.
  5. Analyst Reco.